In a recent study posted to the bioRxiv* preprint server, a team of researchers evaluated the efficacy, immunogenicity, and safety of a novel severe acute respiratory syndrome coronavirus 2 ...
STONY BROOK, N.Y. & ROME--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing and nucleic acid-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback